Evidence map›Paper›PMID 29317370›Full record

ArticleActa biomaterialia2018

3D-printed gelatin scaffolds of differing pore geometry modulate hepatocyte function and gene expression.

Phillip L Lewis, Richard M Green, Ramille N Shah

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 163 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Gelatin as It Is: History and Modernity.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Review
  20. Advances in 3D bioprinting technology for liver regeneration.Hepatobiliary surgery and nutrition · 2022
    Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Phillip L LewisDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, United States; Simpson Querrey Institute for Bionanotechnology, Northwestern University, Chicago, IL, United States. Electronic address: PhillipLewis2015@u.northwestern.edu.
Richard M GreenDivision of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. Electronic address: R-Green2@northwestern.edu.
Ramille N ShahDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, United States; Simpson Querrey Institute for Bionanotechnology, Northwestern University, Chicago, IL, United States; Department of Materials Science and Engineering, Northwestern University, Evanston, IL, United States; Department of Surgery - Organ Transplantation, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. Electronic address: ramille-shah@northwestern.edu.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
Multifunctional Printed Scaffolds for Enhancing Hepatocyte Viability and FunctionK01DK099454 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHAH, RAMILLE N · 2013 to 2017
$652k
NCI NIH HHS P30 CA060553NIDDK NIH HHS K01 DK099454
6 · The paper itself

Abstract

Three dimensional (3D) printing is highly amenable to the fabrication of tissue-engineered organs of a repetitive microstructure such as the liver. The creation of uniform and geometrically repetitive tissue scaffolds can also allow for the control over cellular aggregation and nutrient diffusion. However, the effect of differing geometries, while controlling for pore size, has yet to be investigated in the context of hepatocyte function. In this study, we show the ability to precisely control pore geometry of 3D-printed gelatin scaffolds. An undifferentiated hepatocyte cell line (HUH7) demonstrated high viability and proliferation when seeded on 3D-printed scaffolds of two different geometries. However, hepatocyte specific functions (albumin secretion, CYP activity, and bile transport) increases in more interconnected 3D-printed gelatin cultures compared to a less interconnected geometry and to 2D controls. Additionally, we also illustrate the disparity between gene expression and protein function in simple 2D culture modes, and that recreation of a physiologically mimetic 3D environment is necessary to induce both expression and function of cultured hepatocytes. STATEMENT OF SIGNIFICANCE: Three dimensional (3D) printing provides tissue engineers the ability spatially pattern cells and materials in precise geometries, however the biological effects of scaffold geometry on soft tissues such as the liver have not been rigorously investigated. In this manuscript, we describe a method to 3D print gelatin into well-defined repetitive geometries that show clear differences in biological effects on seeded hepatocytes. We show that a relatively simple and widely used biomaterial, such as gelatin, can significantly modulate biological processes when fabricated into specific 3D geometries. Furthermore, this study expands upon past research into hepatocyte aggregation by demonstrating how it can be manipulated to enhance protein function, and how function and expression may not precisely correlate in 2D models.

Indexed as

Gene Expression RegulationPrinting, Three-DimensionalCell Line, TumorGelatinHepatocytesHumansPorosityTissue ScaffoldsGelatin3D printingLiverScaffold geometryTissue engineering

Identifiers

PMID29317370
PMCPMC5831494
OpenAlexW2782486210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.